Director/PDMR Shareholding
July 08 2008 - 3:40AM
UK Regulatory
RNS Number : 5443Y
Phosphagenics Limited
08 July 2008
NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED PERSONS
This form is intended for use by an issuer to make a RIS notification required by DR 3.1.4R (1).
(1) An issuer making a notification in respect of a transaction relating to
the shares or debentures of the issuer should complete boxes 1 to 16, 23
and 24.
(2) An issuer making a notification in respect of a derivative relating the
shares of the issuer should complete boxes 1 to 4, 6, 8,13, 14, 16, 23
and 24.
(3) An issuer making a notification in respect of options granted to a
director/person discharging managerial responsibilities should complete
boxes 1 to 3 and 17 to 24.
(4) An issuer making a notification in respect of a financial instrument
relating to the shares of the issuer (other than a debenture) should
complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.
Please complete all relevant boxes should in block capital letters.
1. Name of the issuer
PHOSPHAGENICS LIMITED
2. State whether the notification relates to (i) a transaction notified in accordance with DR 3.1.4R(1)(a); or
(ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (as extended by section 328) of the Companies Act 1985; or
(iii) both (i) and (ii)
3. Name of director
Michael Richard Dwyer ASHTON, B.Pharm(Sydney University); MBA (Rutgers University)
4. State whether notification relates to a person connected with a director named in 3 and identify the connected person
This advice dated 08 July 2008 relates to the declared beneficial and legal interest of Mr Ashton to the issued securities of
Phosphagenics Limited held as at the time of his appointment today to the Board of Directors of Phosphagenics Limited.
Mr Ashton has a beneficial and legal entitlement to the 100,000 ordinary Phosphagenics Limited shares that are registered in his name in the
Company's Register of Members.
5. Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a
non-beneficial interest
Refer to the text of 4 above
6. Description of shares (including class), debentures or derivatives or financial instruments relating to shares
Ordinary Fully Paid Shares
7. Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
Michael Richard Dwyer ASHTON
8 State the nature of the transaction
The above mentioned entitlement of Mr Ashton existed prior to and as at the time of his appointment to the Board of Directors of
Phosphagenics Limited as a
Non-Executive Director
9. Number of shares, debentures or financial instruments relating to shares acquired
100,000 ordinary shares as held prior to and as at the date of Mr Ashton's appointment to the Board of Directors
10. Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
0.0151 per cent (Total number of Issued Ordinary Shares: 663,542,406 shares)
11. Number of shares, debentures or financial instruments relating to shares disposed
N/A
12. Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)
N/A
13. Price per share or value of transaction
N/A
14. Date and place of transaction
Mr Ashton's appointment to the Board of Directors - 08 July 2008
15. Total holding following notification and total percentage holding following notification (any treasury shares should not be taken
into account when calculating percentage)
100,000 ordinary shares being 0.0151 per cent of total Issued ordinary shares (663,542,406 shares)
16. Date issuer informed of transaction
Mr Ashton's appointment to the Board of Directors - 08 July 2008
If a person discharging managerial responsibilities has been granted options by the issuer complete the following boxes
17 Date of grant
N/A
18. Period during which or date on which it can be exercised
N/A
19. Total amount paid (if any) for grant of the option
N/A
20. Description of shares or debentures involved (class and number)
N/A
21. Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
N/A
22. Total number of shares or debentures over which options held following notification
N/A
23. Any additional information
Declaration under AIM Listing Rule 17, Schedule Two
Pursuant to Rule 17, Schedule Two, Paragraph (g) of the AIM Listing Rules for Companies, the Company, Phosphagenics Limited, discloses
the following information in relation to Mr M R D Ashton who, with effect from 8 July 2008, has been appointed as a Non-Executive Director
of the Company:
(i) the director's full name and age together with any previous names;
Michael Richard Dwyer ASHTON born in Sydney, NSW, Australia on 21 February 1946
(ii) the names of all companies and partnerships of which the director has been a
director or partner at any time in the previous five years, indicating whether or not
the director is still a director or partner;
COMPANY NAME APPOINTED STATUS
Hikma Plc Nov 2005 Current
Proximagen Plc Dec 2005 Current
Transition Inc Dec 2002 Current
LMANV Dec 2006 Retired July 2007
Skyepharma Plc Mar 1997 Retired June 2006
Somanta Inc Jun 2005 Retired December 2007
The Company, Phosphagenics Limited, confirms that there is no further disclosure obligation required pursuant to Rule 17, Schedule Two,
Paragraph (g)
24. Name of contact and telephone number for queries
Mourice Garbutt, Company Secretary, Phosphagenics Limited + 613 9605 5917
Name and signature of duly authorised officer of issuer responsible for making notification
Mourice Garbutt, Company Secretary, Phosphagenics Limited
Date of notification
8 July 2008
END
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSSWSAASASEDW
Phosphagen. (LSE:PSG)
Historical Stock Chart
From May 2024 to Jun 2024
Phosphagen. (LSE:PSG)
Historical Stock Chart
From Jun 2023 to Jun 2024
